Best R, Walker B R
Department of Medicine, University of Edinburgh, Western General Hospital, UK.
Clin Endocrinol (Oxf). 1997 Aug;47(2):231-6. doi: 10.1046/j.1365-2265.1997.2471061.x.
It has been shown recently that 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) is expressed as at least 2 isozymes. In the liver, 11 beta-HSD1 converts cortisone to cortisol; in the kidney, 11 beta-HSD2 converts cortisol to cortisone. Conventional assessment of 11 beta-HSD activity in vivo has relied on gas chromatographic measurement of the ratios of conjugated cortisol and cortisone metabolites. However, these do not permit distinction between the tissue-specific activities of the enzymes and do not reflect all forms of 11 beta-HSD deficiency. In this report, we have assessed the usefulness of measuring unconjugated cortisol metabolites and free cortisol and cortisone in urine as indices of renal 11 beta-HSD activity in man.
Six healthy male subjects established in sodium balance were given either glycyrrhetinic acid (170 mg t.d.s., to inhibit 11 beta-HSD2), carbenoxolone (100 mg t.d.s., to inhibit both 11 beta-HSD1 and 11 beta- HSD2) or both inhibitors in combination.
Urinary electrolytes were measured and the concentrations of total and unconjugated urinary cortisol and its metabolites were determined by gas chromatography mass spectrometry.
Glycyrrhetinic acid and carbenoxolone inhibited renal 11 beta-HSD2 to a similar degree, as judged by similar sodium retention. As previously reported, conventional measurement of ratios of total cortisol to cortisone metabolites were influenced to a greater extent by glycyrrhetinic acid (100-200% increase in ratio from baseline) than by carbenoxolone (< 30% increase). However, the effect of carbenoxolone was readily detected by measurement of urinary unconjugated cortisol/cortisone (130-480% increase of ratio from baseline) and also by measurement of ratios of unconjugated cortisol metabolites (60-130% increase).
Measurement of free cortisol and cortisone in urine provides the most sensitive index of renal 11 beta-HSD activity. Measurement of total and conjugated urinary steroids is insensitive in circumstances where 11 beta-HSD activity in liver or elsewhere may be abnormal.
最近的研究表明,11β-羟类固醇脱氢酶(11β-HSD)至少以两种同工酶的形式表达。在肝脏中,11β-HSD1将可的松转化为皮质醇;在肾脏中,11β-HSD2将皮质醇转化为可的松。体内11β-HSD活性的传统评估依赖于气相色谱法测定结合型皮质醇和可的松代谢物的比例。然而,这些方法无法区分酶的组织特异性活性,也不能反映11β-HSD缺乏的所有形式。在本报告中,我们评估了测量尿液中未结合的皮质醇代谢物以及游离皮质醇和可的松作为人体肾脏11β-HSD活性指标的实用性。
对6名钠平衡稳定的健康男性受试者给予甘草次酸(每日3次,每次170mg,以抑制11β-HSD2)、生胃酮(每日3次,每次100mg,以抑制11β-HSD1和11β-HSD2)或两种抑制剂联合使用。
检测尿电解质,并通过气相色谱-质谱法测定尿中总皮质醇和未结合皮质醇及其代谢物的浓度。
从钠潴留情况相似判断,甘草次酸和生胃酮对肾脏11β-HSD2的抑制程度相似。如先前报道,总皮质醇与可的松代谢物比例的传统测量受甘草次酸影响更大(比例较基线增加100 - 200%),而生胃酮的影响较小(增加<30%)。然而,通过测量尿中未结合的皮质醇/可的松(比例较基线增加130 - 480%)以及未结合皮质醇代谢物的比例(增加60 - 130%),生胃酮的作用很容易被检测到。
尿液中游离皮质醇和可的松的测量提供了肾脏11β-HSD活性最敏感的指标。在肝脏或其他部位11β-HSD活性可能异常的情况下,尿中总类固醇和结合类固醇的测量不敏感。